The critical shortage of organs isn’t going away. Revising the current guidelines about who should be a donor—and who should be a recipient—might save lives.
New drugs for fatty liver may offer the first skirmish in a growing epidemic.
Several drugs that stop the virus by blocking different pathways are nearing FDA approval.
The cause of hepatitis C was a mystery solved only after years of groundbreaking research. But the battle continues.